Howe & Rusling Inc Illumina, Inc. Transaction History

Howe & Rusling Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$177.23 - $227.44 $10,633 - $13,646	-60 Reduced 82.19%	13 $2,000
Q2 2022 Aug 15, 2022	SELL	$181.58 - $368.0 $95,874 - $194,304	-528 Reduced 87.85%	73 $13,000
Q1 2022 May 10, 2022	SELL	$303.87 - $423.8 $34,945 - $48,737	-115 Reduced 16.06%	601 $210,000
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $35,075 - $42,604	-101 Reduced 12.36%	716 $272,000
Q1 2021 May 13, 2021	SELL	$361.28 - $504.76 $2.59 Million - $3.62 Million	-7,166 Reduced 89.77%	817 $314,000
Q4 2020 Feb 08, 2021	BUY	$292.7 - $370.96 $177,668 - $225,172	607 Added 8.23%	7,983 $2.95 Million
Q3 2020 Nov 06, 2020	BUY	$268.51 - $400.74 $1.98 Million - $2.96 Million	7,376 New	7,376 $2.28 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.